login
  Password reminder
Interventional News
Contact the editor Visit Interventional News Twitter feed Visit Interventional News Facebook page
 

Hansen Medical showcases Magellan robotic system and NorthStar catheter at MEET congress in Italy


Wednesday, 07 Dec 2011 15:31
Magellan robotic system
Magellan robotic system


Hansen Medical showcased its Magellan robotic system at the Multidisciplinary European Endovascular Therapy (MEET) Congress, Rome, Italy (1–3 December 2011). 


The company also exhibited its NorthStar robotic catheter, designed to work with the Magellan robotic system. The NorthStar catheter is designed to simplify and enhance catheter navigation and therapeutic intervention in the peripheral vasculature. The Magellan robotic system and NorthStar robotic catheter are CE-marked and available for sale in Europe. They are 510(k) pending and not available for sale in the United States.


“We are excited to showcase our Magellan robotic system and NorthStar robotic catheter at this foremost exhibition on endovascular therapy, and this is an important event in the initial commercial launch of our new system platform,” said Bruce Barclay, president and CEO of Hansen Medical. “Based on the initial clinical and pre-clinical work and feedback from a number of leading clinicians worldwide, these products have the potential to optimise the way physicians navigate the vasculature. The CE marked system and catheter give physicians maximum flexibility and control through independent distal tip control of a catheter and a sheath as well as through robotic manipulation of a standard guidewire from a centralised, remote workstation. Moreover, this proprietary technology has the ability to provide physicians important clinical benefits by allowing precise and predictable catheter navigation of peripheral vessels.”


The Magellan robotic system and NorthStar robotic catheter are intended to be used to facilitate navigation to anatomical targets in the peripheral vasculature and subsequently provide a conduit for manual placement of therapeutic devices.


Last year, the company announced the completion of its first-in-man study in Europe during which 20 endovascular procedures were performed with an earlier version of the Magellan robotic system, demonstrating its potential to allow physicians to treat peripheral vascular disease, while lessening radiation exposure.




Add New Comment

Most popular


One-year IMPROVE data suggest benefit of EVAR in ruptured aneurysms
Wednesday, 29 Apr 2015
Results from the 12-month data of the randomised controlled IMPROVE trial show that an endovascular strategy is cost-effective when compared to open repair in the treatment of ruptured abdominal ... One-year IMPROVE data suggest benefit of EVAR in ruptured aneurysms

 Yasuaki Arai gets standing ovation after ECIO Honorary Lecture
Friday, 24 Apr 2015
Yasuaki Arai, director of the National Cancer Center Hospital, Tokyo, Japan, and current president of the Japanese Society of Interventional Radiology (JSIR), delivered the Honorary Lecture at the E...  Yasuaki Arai gets standing ovation after ECIO Honorary Lecture

First patient enrolled in Vessix sham-controlled study
Friday, 17 Apr 2015
Boston Scientific has announced that it is taking a new approach to evaluate the performance of its Vessix renal Denervation System. It says it is initiating a study with a novel design to isolate ... First patient enrolled in Vessix sham-controlled study

Features


The challenges of measuring response in interventional oncology
Monday, 30 Mar 2015
An overview of three treatments: ablation, chemoembolization and selective interval radiation therapy, should clarify the challenges of determining tumour response in interventional oncology, write M... The challenges of measuring response in interventional oncology

Revolutionary focused ultrasound still needs to address limitations
Monday, 30 Mar 2015
Alessandro Napoli writes that therapeutic ultrasound still has some technological hurdles that need to be overcome, despite his success with the treatment over the past five years. Revolutionary focused ultrasound still needs to address limitations

Profiles


Gao-Jun Teng
Thursday, 11 Dec 2014
In the future, will interventional radiology be a subspecialty of radiology, or surgery? asks Gao-J... Gao-Jun Teng

José Ignacio Bilbao Jaureguízar
Wednesday, 08 Oct 2014
“No matter what their future orientation, interventional radiologists involved in interventional ... José Ignacio Bilbao Jaureguízar

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions